logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Melarsoprol Versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo

Balasegaram M, Harris SR, Checchi F, Ghorashian S, Hamel C,  et al.
2006-10-01 • Bulletin of the World Health Organization
2006-10-01 • Bulletin of the World Health Organization
OBJECTIVE
To compare the effectiveness of melarsoprol and eflornithine in treating late-stage Gambian trypanosomiasis in the Republic of the Congo.

METHODS
We analysed ...
Journal Article
|
Commentary

Universal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected population in the Republic of Congo

O'Brien DP, Mills C, Hamel C, Ford NP, Pottie K
2009-01-07 • Conflict and Health
2009-01-07 • Conflict and Health
The Pool region of the Republic of Congo is an isolated, conflict-affected area with under-resourced and poorly functioning health care services. Despite significant AIDS-related mortali...
Journal Article
|
Research

Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo

Balasegaram M, Harris SR, Checchi F, Hamel C, Karunakara U
2006-10-01 • Bulletin of the World Health Organization
2006-10-01 • Bulletin of the World Health Organization
OBJECTIVE
In 2002-03, the Republic of the Congo increased the threshold separating stage 1 and 2 cases of human African trypanosomiasis (HAT) from a cerebrospinal fluid (CSF) white c...